LTBP2 and neoplasm: In recent years, more and more studies have found that LTBP2 expression is increased in a variety of malignant tumors, such as nasopharyngeal cancer, esophageal cancer, melanoma, cervical cancer, etc., and its overexpression is significantly related to tumor progression and poor prognosis [14–17].